Hélène Margery

Title: Hélène Margery: Innovator in Cytokine Production Inhibition

Introduction

Hélène Margery is a notable inventor based in Bièrges, Belgium. He has made significant contributions to the field of biotechnology, particularly in methods for inhibiting cytokine production and deoxyribonucleotide triphosphate biosynthesis. With a total of 2 patents, his work has implications for medical advancements and therapeutic applications.

Latest Patents

Hélène Margery's latest patents include a method for inhibiting cytokine production by cells. This invention focuses on applying azo compound derivatives to animal or human cells to inhibit cytokine production and secretion. The method utilizes specific chemical formulas to achieve its effects. Another significant patent involves a process for inhibiting deoxyribonucleotide triphosphate biosynthesis by cells. This process also employs azo derivatives and aims to produce medicines for conditions requiring abnormal DNA production from cells.

Career Highlights

Hélène Margery is associated with Previsan Ag, where he continues to develop innovative solutions in biotechnology. His research has contributed to a deeper understanding of cellular processes and potential therapeutic interventions.

Collaborations

Hélène has collaborated with notable colleagues, including Michel Vandevelde and Michel Goldman. These partnerships have fostered a collaborative environment that enhances research and innovation.

Conclusion

Hélène Margery's work exemplifies the intersection of science and innovation, particularly in the realm of biotechnology. His patents reflect a commitment to advancing medical science and improving therapeutic strategies.